Stay updated with breaking news from Xus Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data from the BE VITAL OLE study, which included patients from the BE COMPLETE and BE OPTIMAL studies, suggests the benefits of bimekizumab in patients with psoriatic arthritis with inadequate response or intolerance to TNF inhibitors were sustained for up to 52 weeis.
Investegate announcements from AssetCo PLC, Prelim results for the year ended 30 Sept 2022
/PRNewswire/ -- A study released today by Cigna (NYSE: CI), a global health service company, finds that triple integration of medical, pharmacy and behavioral...
UCB's Atlanta Warehouse is the first dually certified WELL Platinum and LEED Gold pharmaceutical project in the world and the first WELL Platinum ...
A royal princess came to Smyrna to visit the new U.S. headquarters of global biopharmaceutical company UCB Monday.